Medication info

Glipide Tablet 4 mg (Glymepiride)

Prescription medicationTablet경구Expired
Ingredient · strength
Glimepiride›4mg / 1 tablet
Manufacturer / importer
(주)휴비스트제약
Appearance
Light blue rectangular tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Expired

MFDS item code 201905559 · Approved 2019.08.07

This product's status changed to Expired on 2024.08.07. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement in blood glucose control in type 2 diabetes
Who takes it
Adults
Adult dose
This medication is administered orally once daily. It should be taken before breakfast or just before the first meal. The initial dosage for monotherapy is 1 mg of glymepiride administered once daily, which can be increased by 1 mg at intervals of 1 to 2 weeks. Generally, there is little additional effect at doses above 4 mg, but some patients may respond to doses up to 6 mg or 8 mg. If 4 mg daily dosing fails, ATP

Ingredients

Manufacturer
(주)휴비스트제약

Efficacy & effects

Improvement in blood glucose control in type 2 diabetes

View approved original text

This medication is used to enhance blood glucose control in patients with type 2 diabetes by supplementing dietary therapy and exercise therapy. It can be used alone, but when blood glucose control is insufficient, it can be administered in combination with oral hypoglycemic agents or insulin. Furthermore, in cases where blood glucose control is inadequate with sulfonylureas or metformin monotherapy, it is used in conjunction with metformin. This helps effectively manage blood glucose through various methods and improves the patients' health.

How to take

Adult dose

This medication is administered orally once daily. It should be taken before breakfast or just before the first meal. The initial dosage for monotherapy is 1 mg of glymepiride administered once daily, which can be increased by 1 mg at intervals of 1 to 2 weeks. Generally, there is little additional effect at doses above 4 mg, but some patients may respond to doses up to 6 mg or 8 mg. If 4 mg daily dosing fails, ATP

Precautions

This medication should not be used in insulin-dependent diabetes patients or patients with diabetic ketoacidosis or coma. Additionally, patients allergic to this medication or its components, including sulfonylureas, should not be administered this drug. There is no experience using this medication in patients with severe liver or kidney dysfunction; therefore, switching to insulin therapy is recommended. Pregnant women, women who may become pregnant, and nursing mothers should not take this medication. Patients with severe infections or those undergoing surgery, or those with severe trauma may require insulin therapy. Caution should be exercised in cases of gastrointestinal disturbances such as diarrhea or vomiting that impair food absorption due to the risk of hypoglycemia. Patients with lactose intolerance or certain genetic digestive disorders should also not take this medication. During the first week of treatment, the risk of hypoglycemia is higher, so blood glucose should be closely monitored. Particularly among the elderly, or those in poor nutritional status or who skip meals, or those in case exercise and diet are not balanced, the risk of hypoglycemia is even greater. Patients who frequently consume alcohol or have weakened liver or kidney functions also need to be cautious. Additionally, in cases of endocrine diseases such as thyroid or pituitary abnormalities, the risk of hypoglycemia may increase. If this medication is overdosed or taken with other medications, blood glucose changes may occur, so consultation with a doctor is necessary. This medication may cause hypoglycemic symptoms, including headache, severe hunger, nausea, fatigue, anxiety, confusion, drowsiness, and reduced consciousness. Severe cases may result in coma or seizures, necessitating immediate treatment. Additionally, temporary blurred vision, gastrointestinal discomfort, liver function abnormalities, blood abnormalities, and allergic reactions have been reported. If allergic symptoms such as skin rash or difficulty breathing occur, contact a physician immediately. This medication must be combined with dietary therapy and exercise therapy for blood glucose control, and it is important to take it regularly. In cases of hypoglycemia, sugars should be rapidly consumed, and artificial sweeteners are ineffective, so caution is required. During treatment, regular blood glucose and urine tests should be conducted to verify the drug's effectiveness, and if conditions change, consulting a physician is advised. When used in combination with other drugs, it can affect blood glucose control due to interactions, so all medications being taken must be disclosed. Caution is particularly needed when used with beta-blockers, antibiotics, anticoagulants, and steroids. Pregnant or nursing women should switch to insulin therapy instead of this medication as it may affect the fetus or newborn. In cases of overdose, hypoglycemia can worsen, necessitating immediate emergency treatment, including inducing vomiting, administering activated charcoal, or glucose infusion. This medication’s safety and effectiveness are not established for children, and in elderly patients, dosage adjustments should be made considering reduced kidney function. Finally, this medication should be stored out of the reach of children, and it should be kept in its original container to prevent quality deterioration.

Side effects and when to seek care immediately

Serious side effects

Urticaria, severe swelling (edema), hypotension, respiratory distress, angioedema, anaphylaxis, Stevens-Johnson syndrome (serious mucous membrane reaction), severe allergic reactions, liver dysfunction, jaundice, hepatitis, hemolytic anemia, thrombocytopenia, leukopenia, agranulocytosis, pancytopenia, severe hypoglycemia, seizures, loss of consciousness, coma, thrombocytopenic purpura.

Mild side effects

  • Headache
  • severe hunger
  • nausea
  • vomiting
  • fatigue
  • sleep disturbances
  • anxiety
  • aggression
  • reduced concentration
  • decreased agility or energy
Show 24 more
  • depression
  • confusion
  • speech disturbance
  • aphasia
  • visual disturbances
  • tremors
  • incomplete paralysis
  • sensory disturbances
  • dizziness
  • weakness
  • loss of self-control
  • transient mental confusion
  • drowsiness
  • shallow breathing
  • bradycardia
  • sweating
  • cold and moist skin
  • tachycardia
  • hypertension
  • palpitations
  • angina
  • deep vein thrombosis
  • blurred vision
  • abdominal fullness.

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to protect it from exposure to air and moisture, and it is recommended to store it at room temperature between 1 and 30 degrees Celsius. Storing it this way helps maintain the medication's efficacy and prevents degradation.

Appearance and packaging

Appearance

Light blue rectangular tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.